ASX:UBI (Australia)
Â
Shs Chess Depository Interests US Prohibited repr 1 sh
A$
0.11
(-4.35%)
Dec 24
Business Description
Universal Biosensors Inc
NAICS : 339112
SIC : 3841
ISIN : AU000000UBI2
Share Class Description:
ASX:UBI: Shs Chess Depository Interests US Prohibited repr 1 shDescription
Universal Biosensors Inc is biosensor company in electrochemical cell technology to develop a diverse range of biosensor test strips. The company's platform develops a diverse range of biosensor test strips used in conjunction with point-of-use devices that are used in various industries such as healthcare (point-of-care), wine, food and agriculture. It manufactures and distributes PT-INR coagulation test strips and devices, Xprecia, Stride and Xprecia Prime which are medical devices, Sentia non-medical wine testing products, and Petrackr which is a blood glucose test used in cats and dogs. Geographically, the company generates majority of its revenue from Australia and rest from Americas, Europe and other markets.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 3.65 | |||||
| Equity-to-Asset | 0.72 | |||||
| Debt-to-Equity | 0.16 | |||||
| Debt-to-EBITDA | -0.3 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -3.23 | |||||
| Beneish M-Score | -2 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 19.9 | |||||
| 3-Year EBITDA Growth Rate | 7.4 | |||||
| 3-Year EPS without NRI Growth Rate | 11.3 | |||||
| 3-Year FCF Growth Rate | -15.8 | |||||
| 3-Year Book Growth Rate | -24.5 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 30.16 | |||||
| 9-Day RSI | 36.34 | |||||
| 14-Day RSI | 39.49 | |||||
| 6-1 Month Momentum % | -14.29 | |||||
| 12-1 Month Momentum % | -45.45 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.03 | |||||
| Quick Ratio | 3.75 | |||||
| Cash Ratio | 2.86 | |||||
| Days Inventory | 585.68 | |||||
| Days Sales Outstanding | 94.7 | |||||
| Days Payable | 136.81 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -6.1 | |||||
| Shareholder Yield % | -33.04 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 56.94 | |||||
| Operating Margin % | -182.71 | |||||
| Net Margin % | -175.02 | |||||
| FCF Margin % | -209.35 | |||||
| ROE % | -59.18 | |||||
| ROA % | -40.64 | |||||
| ROIC % | -86.38 | |||||
| ROC (Joel Greenblatt) % | -109.08 | |||||
| ROCE % | -48.93 | |||||
| Years of Profitability over Past 10-Year | 2 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 8.82 | |||||
| PS Ratio | 3.97 | |||||
| PB Ratio | 1.64 | |||||
| Price-to-Tangible-Book | 1.57 | |||||
| EV-to-EBIT | -1.93 | |||||
| EV-to-Forward-EBIT | -7.26 | |||||
| EV-to-EBITDA | -2.07 | |||||
| EV-to-Forward-EBITDA | -24.19 | |||||
| EV-to-Revenue | 3.36 | |||||
| EV-to-Forward-Revenue | 1.34 | |||||
| EV-to-FCF | -1.71 | |||||
| Price-to-Median-PS-Value | 0.85 | |||||
| Price-to-Net-Current-Asset-Value | 2.2 | |||||
| Price-to-Net-Cash | 11 | |||||
| Earnings Yield (Greenblatt) % | -51.83 | |||||
| FCF Yield % | -45.22 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Universal Biosensors Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | 7.081 | ||
| EPS (TTM) (A$) | -0.05 | ||
| Beta | 0.9 | ||
| Volatility % | 48.19 | ||
| 14-Day RSI | 39.49 | ||
| 14-Day ATR (A$) | 0.004933 | ||
| 20-Day SMA (A$) | 0.12025 | ||
| 12-1 Month Momentum % | -45.45 | ||
| 52-Week Range (A$) | 0.105 - 0.3 | ||
| Shares Outstanding (Mil) | 298.07 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Universal Biosensors Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Universal Biosensors Inc Stock Events
| Event | Date | Price(A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Universal Biosensors Inc Frequently Asked Questions
What is Universal Biosensors Inc(ASX:UBI)'s stock price today?
The current price of ASX:UBI is A$0.11. The 52 week high of ASX:UBI is A$0.30 and 52 week low is A$0.11.
When is next earnings date of Universal Biosensors Inc(ASX:UBI)?
The next earnings date of Universal Biosensors Inc(ASX:UBI) is .
Does Universal Biosensors Inc(ASX:UBI) pay dividends? If so, how much?
Universal Biosensors Inc(ASX:UBI) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers